Next, we tested whether compound loss of Dmpk, Six5, Mbnl1 and Dmwd could give rise to a mouse model recapitulating the most of the symptoms in DM1 patients and the more severe CDM manifestations. This evidence concerns the gene SIX5 and myotonic dystrophy type 1.